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Objective: This paper presents a new approach for understanding factors related to physician
adoption of clinical guidelines, using children's vaccine recommendations as a case study.
Methods: The model traces sequential steps, from awareness to agreement to adoption and,
finally, adherence to the guideline. Movement through these stages can be catalyzed or
retarded by many influences, grouped into two major categories: environmental characteris-
tics of the physician's practice, and information characteristics of the guideline. Environmen-
tal characteristics include sociocultural factors, professional characteristics, and practice orga-
nization factors. Information characteristics include the guideline's relative advantage,
complexity, and compatibility with existing guidelines and protocols, as well as mechanisms
of guideline dissemination. Implications: This model can be used to identify characteristics
that will likely impede or facilitate guideline adoption, and to focus dissemination efforts
on key issues.
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INTRODUCTION
There are many reasons that U.S. children do
not receive their immunizations at the appropriate
ages, including difficulties with access to care. How-
ever, even when children successfully gain access,
health care providers frequently fail to offer and pro-
vide immunizations (1, 2). To deal specifically with
this problem, the Healthy People 2000 report set as
a goal to "increase to at least 90% the proportion of
primary care providers who. . . offer immunizations
as appropriate to their patients" (3).
The most publicized issues related to provider
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immunization practice involve inappropriate contra-
indications and missed opportunities for immuniza-
tion. Often overlooked is the question of whether
physicians who care for children understand and fol-
low immunization recommendations.
In ail areas of medicine, the number of clinical
practice guidelines put forth has increased substan-
tially in recent years. Yet relatively little attention
has been paid to the issue of how to disseminate
clinical practice guidelines to influence patient care
most effectively. Unfortunately, the work published
to date has had little impact improving dissemination
methods (4). As a result, many guidelines remain
unfamiliar to physicians and have little effect on clini-
cal practice (5, 6). In this paper, we apply the case
of children's vaccine recommendations to a new para-
digm for understanding the factors related to physi-
cian adoption of clinical guidelines. We believe exam-
ination of this case not only illustrates some of the
recurrent concerns that are relevant to the formula-
tion and implementation of clinical policies in a vari-
ety of settings and clinical domains, but also serves
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as an ideal vehicle to enrich our theoretical under-




There are five reasons why immunization recom-
mendations provide such an important test case for
understanding guideline dissemination:
1. Until fairly recently, there had been a long
period during which a uniform, universal im-
munization schedule was in place and thought
to be generally accepted by most physicians.
Since physician practice rarely changes in this
arena in the absence of a new guideline,
changes can be assessed from a period of rela-
tive stability and temporally associated with
the introduction or modification of specific
guidelines.
2. Considered in the context of other preventive
services delivered by physicians, immuniza-
tion is a "medicalized" procedure unlike, for
example, dietary counseling and behavioral
counseling, which have a more significant psy-
chosocial orientation. Physicians are consis-
tently and broadly trained to give vaccines—a
maneuver that is relatively simple and clearly
considered a typical part of medical practice.
3. The administration of children's vaccines is a
relatively discrete, unambiguous activity that
generally is documented in the ambulatory
care medical record, unlike many preventive
services. One of the sequelae of the concern
with liability over vaccines is that the adminis-
tration (or non administration) of a vaccine
leaves a paper trail.
4. Generally, immunization recommendations
are universal or, occasionally, limited to spe-
cific geographic areas where epidemics have
occurred. Because contraindications for vac-
cine administration are few and usually are
experienced temporarily, it is relatively easy
to determine which immunizations should be
given at a certain age compared to more com-
plex contraindications for many other proce-
dures.
5. Finally, immunization delivery is being incor-
porated into regimens designed to assess of
the quality of care delivered by physicians,
and to rate the effectiveness of health care
plans. Yet the administrative complexities
and practical challenges involved in the mea-
surement of this apparently straightforward
indicator poses important challenges to ef-
forts aimed at assessing more complex indi-
cators.
Despite the importance of studying the dis-
semination of immunization recommendations to
physicians, little is known about this process or the
determinants of recommendation adoption and ad-
herence. Traditionally, physician agreement and
adoption of new immunization recommendations was
taken for granted by medical societies and public
health officials. However, recent studies demonstra-
ting variation in awareness and adoption of new im-
munization recommendations for Hib and hepatitis
B vaccines emphasize that adoption can no longer
be assumed to occur uniformly (7-11).
Each new or revised immunization recommen-
dation increases the complexity of immunization de-
livery and requires a change in practice behavior.
Moreover, the process of disseminating and cultivat-
ing compliance with new immunization recommen-
dations has been compounded by the existence of
several confusing, competing, and sometimes contra-
dictory vaccine administration schedules issued by
different professional and public health bodies. To
correct these inconsistencies, uniform immunization
schedules have been released as a joint effort of the
Advisory Committee on Immunization Practices
(ACIP), the Centers for Disease Control and Preven-
tion, the American Academy of Pediatrics, and the
American Academy of Family Physicians (12). How-
ever, the initial approval of new recommendations
still is not coordinated, as evidenced by recent experi-
ence with varicella vaccine and injectable polio vac-
cine. There continue to be periods of uncertainty for
providers in which ACIP recommendations do not
match those of their own professional association.
A CONCEPTUAL MODEL OF GUIDELINE
ADOPTION AND ADHERENCE
To provide a framework for research into the
determinants of immunization guideline adherence
for the individual practitioner, we constructed and
tested (13) a conceptual model of this process
(Fig. 1). Since that time, we have developed a greater
understanding of the complexity, variety, and interre-
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Fig. 1. Model of the immunization recommendation implementation process.
lationships of the variables affecting each stage of
the process. We have performed additional studies
exploring further the impact of parental factors (14),
policy changes (15, 16), and legal issues (17, 18) on
the adoption and adherence to immunization recom-
mendations. The model presented here is now more
complete in its demonstration of the process and its
determinants with sequential stages from preaware-
ness through implementation and adherence. Ac-
cording to the theoretical base of the model, move-
ment through each stage in the process can be
catalyzed or retarded by such factors as physician
characteristics (19-21), practice organization (22,
23), practice environment (24), and characteristics of
the vaccines and the guidelines themselves (25). This
manuscript further details these factors and identifies
the stage(s) at which they have an effect on the
process.
The many influences on this process are orga-
nized in the model to better understand their com-
plexity and interrelationships. Two broad categories
encompass all others: environmental characteristics
of a physician's practice setting and information char-
acteristics of the recommendation.
Environmental Characteristics
Environmental characteristics include sociocul-
tural, professional, and organizational factors. Each
of these can be broken down further to specific fac-
tors that have an impact on each stage in the process.
Sociocultural factors, seen in the top portion of
Fig. 1, include such things as previous history of epi-
demics, community or school vaccination policies,
and parent demand. Professional and organizational
factors include individual physician characteristics
(e.g., age, specialty), practice characteristics (e.g.,
solo, group), and practice management policies.
Individual Physician Factors
Considerable attention has been given to the
role played by features of individual physicians in
medical innovation diffusion. Eisenberg concluded
that the most important factors influencing clinical
decision making were personal characteristics of indi-
vidual physicians and their interactions within their
profession (19). Individual physician factors, includ-
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ing age and training, have been carefully studied in
regard to the use of laboratory tests and prescription
of drugs (20, 21, 26). Although individual physician
characteristics have been found to be associated with
practice patterns and prescribing styles, these associa-
tions vary with the class of drugs being studied. Linn
found that prescribing patterns of psychotropic drugs
were more likely to be related to characteristics re-
flecting physicians' "values, social position, or social
background" than indicators of medical or scientific
background (27, 28). Stolley noted that physicians
more appropriate in their chloramphenicol prescrib-
ing habits were those who were younger, "more cos-
mopolitan," more modern, and those concerned with
both the psychosocial and quality dimensions of med-
ical care (21). The specific factors influencing medical
decision making have been found to vary among spe-
cialties (29-31), perhaps related to known specialty
differences in individuals' styles of information shar-
ing and patterns of adoption of new treatments (32).
This variation across specialties only complicates our
understanding of the influence of individual factors
on medical practices.
Burt categorized physicians into four groups
based upon the timing of their adoption of tetra-
cyline: eager innovators, early conformers, late
conformers, and deviant laggards (33). Although
associations were noted between some physician
characteristics (e.g., age, number of journal subscrip-
tions maintained, early contact with pharmaceutical
representative) and the date of tetracyline adoption,
Burt reported no attempt to specifically identify indi-
vidual characteristics in each of these groups.
Practice Specific Characteristics
It is increasingly recognized that medicine is not
practiced in a vacuum, but exists within a complex
network of intra- and interorganizational arrange-
ments influencing physician practice patterns (22).
Thus, the ability to influence physician decision mak-
ing must be based on our ability (a) to understand
and affect the organizational context within which
the physician functions, and (b) to recognize the net-
work of organizations that influence activities within
the practice (34).
Becker's data suggests that opinion leaders
within health care organizations are selective in their
support of innovations (35). Mohr speculated that
individual motivation to innovate will be successful
in direct relation to the availability of supportive or-
ganizational resources in a given situation, and in
inverse relation to organizational obstacles to innova-
tion (36). These factors may overpower individual
efforts to adopt or reject new medical treatments. The
effects of group style and peer pressure are thought to
be stronger in more formally organized practices,
such as health maintenance organizations (37). Wil-
liamson noted that the average time from awareness
to adoption of new therapies was shorter for physi-
cians in group practices than those in solo practice
(23). Specifically, increasing time spent with col-
leagues was related to earlier adoption. The interac-
tion between physicians, as fostered in medical
groups, appears to enhance dissemination of informa-
tion about new therapies, and helps legitimize an
innovation (23,38). Eisenberg noted the strong effect
of "educationally influential" physicians within prac-
tices (37).
Other aspects of organizations that play signifi-
cant roles in the diffusion of medical information and
technology adoption include organizations' formal
quality assurance efforts, methods used to enforce
group standards of care, information management
systems, patient flow efficiency, and delegation of
patient care tasks to nurses and aides. These concrete
factors, which reflect Mohr's supportive organiza-
tional resources or obstacles, (36) have received little
formal assessment.
Organizational policies and procedures probably
play a strong role in the ability of physicians within
a practice to achieve high immunization rates among
their pediatric patients. Appropriate times for well-
child visits to physicians (tied to the ages when vac-
cines are to be given) are widely accepted, and likely
assist in achieving high vaccine rates. It is a near
uniform practice to record in a specially designed
location in pediatric patient charts all vaccines admin-
istered, along with manufacturer batch information,
and dates of administration. The availability of this
data has helped make vaccine compliance a favorite
target for practice's quality assurance efforts.
Practice Management Policies
Physicians, though operating within organiza-
tions, also interact with and are influenced by outside
physicians. Coleman, in a study of tetracycline adop-
tion soon after its release, determined that the behav-
ior of a physician's peers was the strongest determi-
nant of practice behavior (39). Those who were late
adopters had peers who were late adopters. The in-
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fluence of physicians outside one's practice is likely
greatest for physicians in smaller groups or solo
practice.
Physicians' medical practices are influenced in-
creasingly by outside forces. Medical care decisions
are guided by the requirements of health care payors
for second opinions for surgical procedures, and limi-
tations in drug prescribing options through restrictive
formularies. Carey and Weis suggest that despite low
vaccination rates in general for medicaid patients,
that those enrolled in capitated arrangements might
fare somewhat better (24).
State or local regulations specifying vaccine re-
quirements for public school attendance are felt to
exert strong influences on physicians' vaccine prac-
tices (17). Some state and local health departments
are called upon to set local vaccine recommendations
to meet recent vaccine-preventable disease out-
breaks. They then also serve to educate physicians
about these recommendations.
Information Characteristics
Information characteristics comprise specific
features of the guideline itself and the mechanisms
of the dissemination process. Information character-
istics unique to each immunization recommendation,
seen in the lower portion of Fig. 1, might involve the
relative advantage of the revised or new recommen-
dation, its complexity for providers and parents, and
its compatibility with existing recommendations. The
mechanisms of dissemination involve the choice of
information sources (e.g., medical or lay, official or
unofficial), the credibility of those sources, other
methods of dissemination, and the initial acceptance
by local medical opinion leaders.
Guideline Specific Factors
Innovation theory has taught that certain fea-
tures of innovations themselves enhance their likeli-
hood of being adopted (25,30). Three specific charac-
teristics—relative advantage, complexity, and
compatibility—are found to be the most reliable pre-
dictors of adherence (40). Relative advantage refers
to the degree to which the innovation is perceived
as being better than that which it is intended to re-
place. Two specific dimensions of relative advantage
are the innovation's scientific performance and cost.
Complexity refers to the degree to which the innova-
tion is difficult to understand or use. Compatibility
is the degree to which the innovation is seen as con-
gruent with existing modes of operation, values,
and needs.
Vaccine practices are influenced by characteris-
tics of specific recommendations such as the timing
recommended or the way in which contraindications
are identified, or even the wording used in these
recommendations. The notions of relative advantage,
complexity, and compatibility seem highly relevant
to explaining variation in vaccine protocol adherence.
The past success of vaccine recommendation compli-
ance may be explained by vaccines' perceived relative
advantage (clear efficacy in disease prevention), lim-
ited complexity (recommendations traditionally easy
to understand and injections themselves easy to ad-
minister), and high compatibility with medical office
practice (injections are well accepted by parents pa-
tients and fall well within the traditional scope of
work of physicians). An example of a successful in-
stance of implementation of an innovation is the case
of the change in Haemophillus influenza, type b, rec-
ommendations where adoption by physicians was rel-
atively rapid (10). The relative advantage offered by
the new recommendation was quite easy to convey
to physicians, given the promise of disease protection
through the earlier months of life carrying the great-
est morbidity and mortality risk. Further, compatibil-
ity was high, given that the added vaccine doses were
to be given at the same 2-, 4-, and 6-month well child
visits as recommended for diptheria, pertussis, and
tetanus (DPT). Finally, complexity was low for this
recommendation change since the major issue was
merely a change in the timing of the first vaccine.
On the other hand, growing resistance of physi-
cians and patients to recent and upcoming vaccine
recommendations can be understood as emerging in
a milieu that is itself changing. With the emergence
of new vaccine recommendations for diseases per-
ceived as less severe or life-threatening (e.g., rotavi-
rus, varicella) (14), relative advantage will be less
clear, complexity will increase, and compatibility can-
not be taken for granted. The perception of relative
advantage of new recommendations wanes as the
living historical memory of dreaded childhood dis-
eases diminishes, affecting the judgments of parents
and physicians. Further, additional vaccines involve
additional costs to parents and payors for children's
health maintenance. On the other hand, physicians
did not initially manifest consensus about the relative
advantage of universal vaccination for hepatitis B
(8, 9, 41), given that it is a disease with well-known
236 Freed et al.
lifestyle risk factors. Each new vaccine recommenda-
tion or modification increases the complexity of the
entire process. As more and more vaccines are added
to the schedule, room for confusion and error grows.
Guideline Dissemination Factors
Relatively little research has been devoted to
the question of dissemination of guidelines in the area
of vaccines. In a study of 12 organizations (HMO's,
insurers, specialty societies) that develop and use
practice guidelines, Audet, Greenfield, and Field sur-
veyed a variety of professional, commercial and prac-
tice based organizations who were developing of dis-
seminating medical practice guidelines (42). They
found that less emphasis was placed on implementa-
tion than on guideline development. In general, orga-
nizations that both develop and use guidelines (i.e.,
payers and delivery organizations) appeared to de-
vote more attention to implementation than did pro-
fessional organizations (i.e., medical specialty socie-
ties). Less systematic dissemination of guidelines
made updating of guidelines more difficult. Adding
to the complexity is the discovery that different spe-
cialties have varying preferences for the source of
new vaccine recommendations (43, 44).
In total, the process appears complex and convo-
luted, suggesting the difficulties encountered in dis-
seminating new guidelines to achieve widespread ad-
herence. The following sections examine each step
in the process and the particular influences that may
have an impact upon them.
Awareness. Before any publicity is released
about a new recommendation, physicians are in a
state of preawareness. The process of implementing
a new immunization recommendation begins with
awareness, where physicians learn about the guide-
line. The sources of this new information may include
communications from the Centers for Disease Con-
trol, specialty societies, and local health departments,
articles in medical journals, or television and other
lay media efforts. Colleagues are also a source of
information for many practitioners. The mechanism
of dissemination unique to these sources may have
a direct impact on their success in promoting
awareness.
The individual characteristics of physicians also
play a role in awareness. Physicians of different ages,
specialties, and professional society affiliation may
have differential access to information about a new
recommendation. They vary in the number of meet-
ings attended, the amount of time spent reading med-
ical literature, and the attention devoted to a particu-
lar medical issue (in this example, childhood
immunization).
Agreement. The next step in the process,
agreement, occurs when a physician conceptually un-
derstands and approves of the rationale for a recom-
mendation. Movement toward agreement is influ-
enced by a combination of factors, most importantly
(1) credibility of the information source, (2) the rela-
tive advantage of the new recommendation over the
status quo, (3) the complexity of the new recommen-
dation, and (4) agreement by local medical leaders.
Credibility of the information source is essential in
fostering trust in the information presented. Con-
cerns about liability and patient care will make physi-
cians hesitant to accept new recommendations from
sources not known for their accuracy or complete-
ness. Increasingly, sources of information about im-
munization recommendations must "prove their
case"—i.e., offer convincing evidence that the new
or revised recommendation offers an advantage over
the existing schedule. The importance of this factor
was demonstrated by low rates of physician
agreement with universal infant hepatitis B immuni-
zation (8, 9).
Previous research also has demonstrated the role
that local medical opinion leaders play in fostering
widespread agreement with innovation (37). Fre-
quently, there are respected physicians in the commu-
nity who guide colleagues in establishing community
norms and determining standards of care. Their pub-
lic agreement with a new recommendation may pro-
mote agreement by others (35).
Physician and practice characteristics also influ-
ence agreement. For example, members of specialty
societies may be more likely to agree with a recom-
mendation from their own organization. Also, rates
of agreement with new recommendations have been
shown to differ by practice type (e.g., solo, group,
public, HMO) (8). This may reflect the nature of
the individual physician who gravitates to a certain
practice type.
Adoption. The next step is adoption, where phy-
sicians move from an abstract and intellectual con-
cept (agreement) to a concrete endorsement of the
recommendation to patients and preparations to alter
clinical practice accordingly. Environmental factors
involved in achieving this stage include the size and
complexity of the practice organization, physician
characteristics, and local or state vaccine require-
ments for school entry. Informational factors include
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the complexity of the recommendation, its relative
advantage over current recommendations, and its
compatibility with existing recommendations (45).
Elements of a physician's practice setting often
influence adoption (46). Physicians in small, indepen-
dent, solo or two-physician practices may have little
difficulty adopting new immunization recommenda-
tions; the process may be as simple as ordering a new
product and training a small number of office staff.
In a larger practice or HMO, the process of adoption
often requires administrative approval from a clinical
practice committee or from a third-party payer. In
this setting, if approval is given, adoption of the new
policy would be rapid and widespread, affecting many
physicians. Conversely, if approval is denied, few if
any physicians in the organization would adopt the
change. Additionally, outside influences, such as re-
quirements for school or day care attendance set by
local or state ordinance, can foster and even hasten
adoption of a new recommendation by influencing
patient demand even when agreement with it is
minimal.
The more complex a new recommendation, the
longer it likely will take to adopt. Physicians must
determine the best method to put a recommendation
into action, often based on logistical concerns, (e.g.,
record-keeping, scheduling). The compatibility of the
new recommendation with the immunization sched-
ule already in place can also impact on the rapidity
of adoption. For example, a new recommendation
that necessitates additional office visits imposes many
more difficulties than one that substitutes or adds
injections at the regularly scheduled well-child visits.
Adherence. The final stage is adherence to the
new recommendation. This involves the net effect or
outcome: whether or not patients consistently receive
immunizations as recommended. Issues at work in
this stage include the environmental factors of parent
agreement or demand for the immunization and prac-
tice implementation policies, and informational fac-
tors related to complexity of the new recommenda-
tion and compatibility with existing immunization
schedules and recommendations.
Parental agreement with new immunization rec-
ommendations may be influenced by many informa-
tion sources. Physician recommendations, friends,
school or day care requirements, and even the news
media play a role in parents' impression of the safety,
efficacy, and need for vaccines. Parental agreement
is essential for a child to actually receive the vaccine.
In some situations, parental demand for a vaccine
required for school or day care will influence a physi-
cian to offer that vaccine, regardless of whether he
agrees with the recommendation.
Also affecting adherence is the manner in which
a new recommendation is implemented vis-a-vis ex-
isting practice. For example, the addition of hepatitis
B vaccine to the primary immunization series re-
quired that infants receive three injections at one or
more well-child visit. Many parents, nurses, and even
physicians initially balked at giving multiple injec-
tions (41), the alternative, scheduling another ap-
pointment, affected adherence to that recommenda-
tion by delaying immunization receipt. Finally, the
complexity of a new recommendation may prove con-
fusing for physicians, office staff, and parents. For
example, changes in the recommended age for ad-
ministration of a vaccine may require the "relearn-
ing" of standard routines by office nurses, revisions
to parent education materials, and an effective mech-
anism to identify children who may be missed be-
cause of the change.
LIMITATIONS TO THE MODEL
The model implies that all stages, from aware-
ness to adherence, are equally significant and that
progression through one stage is essential to reach
the next. However, some influences on physician be-
havior may be so great as to cause stages to be
skipped. For example, our empirical test of the model
Fig. 2. Effect of 95% progression through each stage in the awareness-to-adherence model.
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(13) identified several physicians who had adopted
the universal hepatitis B vaccine recommendation
even though they did not agree with it. Analysis of
the factors responsible found that both parental pres-
sures and community practice norms resulted in
this phenomenon.
The model also does not demonstrate that for
specific recommendations or guidelines, certain
stages may be more difficult to achieve than others.
However, the model does allow for the identification
of the stage at which the progression to adherence
is arrested. Then, the factor responsible may be "di-
agnosed" and "treated."
IMPLICATIONS FOR PRACTICE
The model presented here has an approach simi-
lar to others in the literature that have looked at
changing patient behavior. Specifically, it is consis-
tent with the recommendation from Prochaska that
investigators shift from the perception that behavior
change is a specific action to one that involves stages
of progression (47). However, in contrast to individ-
ual health-related behaviors, the risk of "relapse"
or returning to the previous prerecommendation is
minimal (48).
The concept of movement through sequential
stages involves certain mathematical consequences
regarding population-based estimates of eventual ad-
herence to a guideline. For example, even if 95% of
physicians achieve each step in the process, the result
is only an 80% adherence rate (Fig. 2)—a potential
problem when striving to achieve herd immunity or
other large-scale population coverage. Thus, if wide-
spread adherence to any guideline follows a rational
series of stages, it necessarily involves significant
"buy-in" at each stage of the process. This places
considerable importance on effective guideline dis-
semination.
This conceptual model of the process of imple-
menting immunization recommendations has uses for
both research and practice. Although designed for
immunizations specifically, modification of individual
factors will allow its use in predicting or following
adoption of other guidelines. For organizations or
governmental entities that craft and promulgate prac-
tice guidelines, early recognition of the potential pit-
falls along the way to adoption and adherence will
facilitate the planning process and suggest effective
strategies for dissemination.
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